Lawrence Steinman honored for research on ties between EBV, MS
Lawrence Steinman, MD, a professor of neurology who is leading the development of Pasithea Therapeutics‘ PAS002 for the treatment…
Articles by Teresa Carvalho, MS
CerraCap invests in Predicta Med’s autoimmune disease platform
The startup company Predicta Med has received an investment from CerraCap Ventures to advance its leading platform focused…
Tevogen Plans Novel T-cell Therapies Aimed at EBV in MS, Cancer
Tevogen Bio has announced plans to develop T-cell therapies targeting the Epstein-Barr virus (EBV), a herpes virus known to…
Landos, Johns Hopkins Partner to Advance Potential MS Oral Therapy
Landos Biopharma has entered into a research partnership with Johns Hopkins University School of Medicine focused on advancing LABP-66 as a potential…
MSAA Is ‘Improving Lives Through Art’
The Multiple Sclerosis Association of America (MSAA) is inviting people to participate in its Improving Lives Through…
DC United Goals Now Worth Up to $20,000 for National MS Society
D.C. United and its official sponsor, Leidos, opened a campaign to donate up to $20,000 to the National Multiple…
Safety Board Says Phase 2 Temelimab Trial Should Move Forward
A Phase 2a clinical trial evaluating GeNeuro‘s investigational antibody temelimab as a treatment for relapsing multiple sclerosis (MS)…
BMS Grants to National MS Society, Others Aim for Diversity in Care and Trials
The National Multiple Sclerosis Society was among 56 nonprofit organizations chosen by Bristol Myers Squibb to share an $11 million…
Tool to Potentially Diagnose MS via Eye Movements Gets $2.5M Funding Boost
C. Light Technologies announced it raised $2.5 million in seed funding to further develop a noninvasive eye tracking device that…
MS Society of Canada Grant Supports Trial of Metformin in Young Patients
Multiple Sclerosis Society of Canada have given CA$400,000 (about $312,500) to support a pilot clinical trial investigating the potential…
Online Art Auction Supports National MS Society
An online auction event supporting the National Multiple Sclerosis Society is is running through Feb. 13 on Facebook.
New Center to Advance Research on MS, Neurovascular Disorders
A $2.5 million donation from the Simon Family Trust is supporting the creation of a new center of expertise to…
European Project Uses Artificial Intelligence to Help Improve Patient Care
The recently launched BRAINTEASER project focuses on the use of artificial intelligence (AI) technology to improve the care of patients…
Age Found to Be Main Driver of MS Disability, Patient Therapy Response
Age is a main driver of disability in multiple sclerosis (MS) and has a key influence on patients’ therapeutic responses…
New Study Will Assess Tysabri Effects on MS Cognitive Fatigue
Researchers from the Kessler Foundation will launch a new study investigating the effects of Tysabri (natalizumab) on cognitive…
Start2Cure Foundation Awards Grant to MS Gene Therapy Project
Start2Cure Foundation is funding a research project that will investigate the potential of a gene therapy approach to treat …
Air Pollution, Once Inhaled, Seen to Trigger Inflammation in RRMS Patients
Exposure to air pollution, particularly to particulate matter 10 (PM10), small airborne and inhalable particles, may trigger inflammatory reactions in people…
Tysabri Superior to Gilenya at Easing Activity in RRMS, Study Reports
Treatment with Tysabri (natalizumab) was more effective than Gilenya (fingolimod) in helping people with relapsing–remitting multiple sclerosis (RRMS)…
People With MS Invited to Submit Their Art for 2021 MSAA Art Showcase
People with multiple sclerosis (MS) are invited to submit their artwork to the Multiple Sclerosis Association of America‘s (MSAA)…
Newly Discovered Type of Immune Cells May Be Key in Treating MS
A recently identified group of immune cells saved damaged nerve cells from death and promoted nervous system repair, a new…
Caregivers of Youth With MS, Other Ills Invited to Survey on Mental Health
Access to mental health services for children with a rare disease or other medical or mental health disorder is the…
Risk Factors for Unemployment in People With MS Identified in Study
Factors related to disease and personality, as well as specific health-related behaviors, are among the main determinants that can put…
Compounds Targeting Inflammatory C-reactive Protein Under Study in Australia
A search is on for an anti-inflammatory treatment targeting the C-reactive protein — CRP, a biomarker of inflammation produced by the liver…
Hypertension Quite Common Among MS Patients in US, Study Finds
Hypertension is considerably more common among people with multiple sclerosis (MS) in the United States than among those…
High Co-occurrence of Psychiatric, Cardiovascular Diseases in MS, Study Reports
People with multiple sclerosis (MS) show a high occurrence of comorbidities — two diseases occurring in one person…
Siemens Healthineers, Novartis Partner to Develop NfL Diagnostic Test
The development of a diagnostic test using neurofilament light chain (NfL) — a biomarker for nerve cell damage —…